z-logo
open-access-imgOpen Access
Kindlin‐1 modulates the EGFR pathway and predicts sensitivity to EGFR inhibitors across cancer types
Author(s) -
Azorin Paula,
Bonin Florian,
Tariq Zakia,
Petitalot Ambre,
Coussy Florence,
Marangoni Elisabetta,
Becette Veronique,
Denoux Yves,
VincentSalomon Anne,
Le Tourneau Christophe,
Larbi Cherif Linda,
Klijanienko Jerzy,
Kamal Maud,
Bièche Ivan,
Lidereau Rosette,
Driouch Keltouma
Publication year - 2022
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.813
Subject(s) - epidermal growth factor receptor , cancer research , egfr inhibitors , cell culture , cancer cell , cancer , medicine , microbiology and biotechnology , receptor , biology , chemistry , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here